Septic shock is associated with receptor for advanced glycation end products ligation of LPS

Journal of Immunology

Volumn 186, Issue 5, 2011, Pages 3248-3257

  Yamamoto, Yasuhiko ^a   Harashima, Ai ^a   Saito, Hidehito ^a   Tsuneyama, Koichi ^b   Munesue, Seiichi ^a   Motoyoshi, So ^a   Han, Dong ^a   Watanabe, Takuo ^a   Asano, Masahide ^c   Takasawa, Shin ^d   Okamoto, Hiroshi ^e   Shimura, Satoshi ^a   Karasawa, Tadahiro ^a   Yonekura, Hideto ^f   Yamamoto, Hiroshi ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d NARA MEDICAL UNIVERSITY   (Japan)

^e TOHOKU UNIVERSITY   (Japan)

^f KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BACTERIUM LIPOPOLYSACCHARIDE; ENDOTHELIN 1; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LUCIFERASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENZYME ACTIVITY; LETHALITY; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; SEPTIC SHOCK; TISSUE INJURY;

AMINO ACID SEQUENCE; ANIMALS; BINDING, COMPETITIVE; CELL LINE, TUMOR; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION MEDIATORS; LIGANDS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROTEIN BINDING; RATS; RECEPTORS, IMMUNOLOGIC; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952751056     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002253     Document Type: Article

References (42)

1. Morrison, D. C., and J. L. Ryan. 1987. Endotoxins and disease mechanisms. Annu. Rev. Med. 38: 417-432.
2. Raetz, C. R. H. 1990. Biochemistry of endotoxins. Annu. Rev. Biochem. 59: 129-170.
3. Glauser, M. P., G. Zanetti, J. D. Baumgartner, and J. Cohen. 1991. Septic shock: pathogenesis. Lancet 338: 732-736.
4. Parrillo, J. E. 1993. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328: 1471-1477.
5. Engelberts, I., E. J. von Asmuth, C. J. van der Linden, andW. A. Buurman. 1991. The interrelation between TNF, IL-6, and PAF secretion induced by LPS in an in vivo and in vitro murine model. Lymphokine Cytokine Res. 10: 127-131.
6. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088. (Pubitemid 29001265)
7. da Silva Correia, J., K. Soldau, U. Christen, P. S. Tobias, and R. J. Ulevitch. 2001. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276: 21129-21135.
8. Chassin, C., M. Picardeau, J. M. Goujon, P. Bourhy, N. Quellard, S. Darche, E. Badell, M. F. d'Andon, N. Winter, S. Lacroix-Lamandé, et al. 2009. TLR4-and TLR2-mediated B cell responses control the clearance of the bacterial pathogen, Leptospira interrogans. J. Immunol. 183: 2669-2677.
9. Triantafilou, K., M. Triantafilou, and R. L. Dedrick. 2001. A CD14-independent LPS receptor cluster. Nat. Immunol. 2: 338-345.
10. Miyake, K., H. Ogata, Y. Nagai, S. Akashi, and M. Kimoto. 2000. Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1. J. Endotoxin Res. 6: 389-391. (Pubitemid 32241949)
11. Wright, S. D., S. M. Levin, M. T. Jong, Z. Chad, and L. G. Kabbash. 1989. CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J. Exp. Med. 169: 175-183.
12. El-Samalouti, V. T., J. Schletter, H. Brade, L. Brade, S. Kusumoto, E. T. Rietschel, H. D. Flad, and A. J. Ulmer. 1997. Detection of lipopolysaccharide (LPS)-binding membrane proteins by immuno-coprecipitation with LPS and anti-LPS antibodies. Eur. J. Biochem. 250: 418-424.
13. Malhotra, R., and M. I. Bird. 1997. L-selectin: a novel receptor for lipopolysaccharide and its potential role in bacterial sepsis. Bioessays 19: 919-923.
14. Malhotra, R., R. Priest, M. R. Foster, and M. I. Bird. 1998. P-selectin binds to bacterial lipopolysaccharide. Eur. J. Immunol. 28: 983-988.
15. Hampton, R. Y., D. T. Golenbock, M. Penman, M. Krieger, and C. R. Raetz. 1991. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 352: 342-344.
16. Bierhaus, A., P. M. Humpert, M. Morcos, T. Wendt, T. Chavakis, B. Arnold, D. M. Stern, and P. P. Nawroth. 2005. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 83: 876-886.
17. Inagi, R., Y. Yamamoto, M. Nangaku, N. Usuda, H. Okamato, K. Kurokawa, C. van Ypersele de Strihou, H. Yamamoto, and T. Miyata. 2006. A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice. Diabetes 55: 356-366. (Pubitemid 43343264)
18. Yamamoto, Y., I. Kato, T. Doi, H. Yonekura, S. Ohashi, M. Takeuchi, T. Watanabe, S. Yamagishi, S. Sakurai, S. Takasawa, et al. 2001. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J. Clin. Invest. 108: 261-268.
19. Scaffidi, P., T. Misteli, and M. E. Bianchi. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195.
20. Hofmann, M. A., S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, et al. 1999. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889-901. (Pubitemid 29375048)
21. Sousa, M. M., S. D. Yan, D. Stern, and M. J. Saraiva. 2000. Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation. Lab. Invest. 80: 1101-1110.
22. Chavakis, T., A. Bierhaus, N. Al-Fakhri, D. Schneider, S. Witte, T. Linn, M. Nagashima, J.Morser, B. Arnold, K. T. Preissner, and P. P. Nawroth. 2003. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J. Exp. Med. 198: 1507-1515.
23. Yan, S. D., X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, et al. 1996. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691. (Pubitemid 26282167)
24. Abeyama, K., D. M. Stern, Y. Ito, K. Kawahara, Y. Yoshimoto, M. Tanaka, T. Uchimura, N. Ida, Y. Yamazaki, S. Yamada, et al. 2005. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J. Clin. Invest. 115: 1267-1274.
25. Liliensiek, B., M. A. Weigand, A. Bierhaus, W. Nicklas, M. Kasper, S. Hofer, J. Plachky, H. J. Gröne, F. C. Kurschus, A. M. Schmidt, et al. 2004. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J. Clin. Invest. 113: 1641-1650.
26. Myint, K. M., Y. Yamamoto, T. Doi, I. Kato, A. Harashima, H. Yonekura, T.Watanabe, H. Shinohara,M. Takeuchi, K. Tsuneyama, et al. 2006. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin. Diabetes 55: 2510-2522. (Pubitemid 44871151)
27. Hill, M. R., S. Clarke, K. Rodgers, B. Thornhill, J. M. Peters, F. J. Gonzalez, and J. M. Gimble. 1999. Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia. Infect. Immun. 67: 3488-3493.
28. Kaplan, E., and P. Meier. 1958. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53: 457-816.
29. Yonekura, H., Y. Yamamoto, S. Sakurai, R. G. Petrova, M. J. Abedin, H. Li, K. Yasui, M. Takeuchi, Z. Makita, S. Takasawa, et al. 2003. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem. J. 370: 1097-1109. (Pubitemid 36399105)
30. Randriamampita, C., and A. Trautmann. 1987. Ionic channels in murine macrophages. J. Cell Biol. 105: 761-769. (Pubitemid 18043839)
31. Sakurai, S., Y. Yamamoto, H. Tamei, H. Matsuki, K. Obata, L. Hui, J. Miura, M. Osawa, Y. Uchigata, Y. Iwamoto, et al. 2006. Development of an ELISA for esRAGE and its application to type 1 diabetic patients. Diabetes Res. Clin. Pract. 73: 158-165.
32. Harashima, A., Y. Yamamoto, C. Cheng, K. Tsuneyama, K. M. Myint, A. Takeuchi, K. Yoshimura, H. Li, T. Watanabe, S. Takasawa, et al. 2006. Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression. Biochem. J. 396: 109-115. (Pubitemid 43764502)
33. Niwa, M., K. C. Milner, E. Ribi, and J. A. Rudbach. 1969. Alteration of physical, chemical, and biological properties of endotoxin by treatment with mild alkali. J. Bacteriol. 97: 1069-1077.
34. Zähringer, U., B. Lindner, Y. A. Knirel, W. M. van den Akker, R. Hiestand, H. Heine, and C. Dehio. 2004. Structure and biological activity of the short-chain lipopolysaccharide from Bartonella henselae ATCC 49882T. J. Biol. Chem. 279: 21046-21054.
35. Frecer, V., B. Ho, and J. L. Ding. 2000. Interpretation of biological activity data of bacterial endotoxins by simple molecular models of mechanism of action. Eur. J. Biochem. 267: 837-852.
36. Ogura, M., N. Nakamichi, K. Takano, H. Oikawa, Y. Kambe, Y. Ohno, H. Taniura, and Y. Yoneda. 2006. Functional expression of A glutamine transporter responsive to down-regulation by lipopolysaccharide through reduced promoter activity in cultured rat neocortical astrocytes. J. Neurosci. Res. 83: 1447-1460.
37. Deane, R., S. Du Yan, R. K. Submamaryan, B. LaRue, S. Jovanovic, E. Hogg, D. Welch, L. Manness, C. Lin, J. Yu, et al. 2003. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 9: 907-913.
38. Cataldegirmen, G., S. Zeng, N. Feirt, N. Ippagunta, H. Dun, W. Qu, Y. Lu, L. L. Rong, M. A. Hofmann, T. Kislinger, et al. 2005. RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NFkappaB. J. Exp. Med. 201: 473-484.
39. Shindo, T., H. Kurihara, Y. Kurihara, H. Morita, and Y. Yazaki. 1998. Upregulation of endothelin-1 and adrenomedullin gene expression in the mouse endotoxin shock model. J. Cardiovasc. Pharmacol. 31(Suppl 1): S541-S544.
40. Bucciarelli, L. G., T. Wendt, W. Qu, Y. Lu, E. Lalla, L. L. Rong, M. T. Goova, B. Moser, T. Kislinger, D. C. Lee, et al. 2002. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation 106: 2827-2835. (Pubitemid 35396983)
41. Zhang, H., S. Tasaka, Y. Shiraishi, K. Fukunaga, W. Yamada, H. Seki, Y. Ogawa, K. Miyamoto, Y. Nakano, N. Hasegawa, et al. 2008. Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury. Am. J. Respir. Crit. Care Med. 178: 356-362.
42. van Zoelen, M. A., A. M. Schmidt, S. Florquin, J. C. Meijers, R. de Beer, A. F. de Vos, P. P. Nawroth, A. Bierhaus, and T. van der Poll. 2009. Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice. J. Infect. Dis. 200: 765-773